Friday, June 18, 2021

AstraZeneca

Use all vaccine options to beat Covid, EMA tells EU

This comes as several countries limit the use of jabs like AstraZeneca and Johnson & Johnson and opt instead for vaccines like Pfizer and Moderna.

‘Mix-and-match’ for Pfizer, AstraZeneca jabs still being studied, says Khairy

He says the issue has been raised with the Covid-19 Vaccine Supply Access Guarantee Special Committee but no final decision has been made.

Clotting concerns see more restrictions for AstraZeneca jab in Australia

Australia now recommends that the AstraZeneca vaccine should not be given to people under 60.

AstraZeneca hits snag in Covid drug development

The drug, which has been undergoing final clinical trials to assess its safety and efficacy, failed its main goal to treat Covid-19 symptoms in exposed patients.

EMA official says remarks on AstraZeneca jab ‘not interpreted correctly’

Marco Cavaleri says the vaccine 'maintains a favourable benefit risk profile in all ages but particularly in the elderly above 60'.

EMA official suggests ditching AstraZeneca jab

But the EMA's head of vaccine strategy acknowledges that incidents of blood clots are very rare, and that the vaccination programme in the UK is going well.

Thai-made AstraZeneca vaccines causing delays across Southeast Asia

Questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner.

Penang scraps plan to buy vaccine after Putrajaya assures of supply

Chief Minister Chow Kon Yeow says the best case scenario is to finish the state vaccination drive by August or September.

Vaccination for media personnel to begin Wednesday

However, the number of vaccine recipients among the media has not been decided.

Malaysia lulus pendaftaran bersyarat AstraZeneca buatan kilang Thailand

Siam Bioscience Co. Ltd, adalah pengilang kedua yang akan menjadi sumber bekalan vaksin AstraZeneca untuk kegunaan PICK di Malaysia.

Chile limits use of AstraZeneca after blood clot case

The shot will be administered only to people aged 45 and over, as a 'preventative and proactive measure' pending further investigation.

First case of AstraZeneca jab blood clotting recorded in South Korea

A group of German scientists claim to have found the cause of the rare blood clots.

Other News